Braxia Scientific (XCNQ:BRAX) EV-to-EBIT : -0.20 (As of May. 27, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Braxia Scientific's Enterprise Value is C$1.93 Mil. Braxia Scientific's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-9.73 Mil. Therefore, Braxia Scientific's EV-to-EBIT for today is -0.20.

The historical rank and industry rank for Braxia Scientific's EV-to-EBIT or its related term are showing as below:

XCNQ:BRAX' s EV-to-EBIT Range Over the Past 10 Years
Min: -6.15 Med: -0.39 Max: -0.01
Current: -0.2

During the past 3 years, the highest EV-to-EBIT of Braxia Scientific was -0.01. The lowest was -6.15. And the median was -0.39.

XCNQ:BRAX's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs XCNQ:BRAX: -0.20

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Braxia Scientific's Enterprise Value for the quarter that ended in Dec. 2023 was C$3.15 Mil. Braxia Scientific's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-9.73 Mil. Braxia Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -309.18%.

Braxia Scientific EV-to-EBIT Historical Data

The historical data trend for Braxia Scientific's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific EV-to-EBIT Chart

Braxia Scientific Annual Data

Trend

Mar21

Mar22

Mar23

EV-to-EBIT

-1.65

-0.28

-0.40

Braxia Scientific Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial												-0.39	-0.40	-0.35	-0.35	-0.32

Competitive Comparison of Braxia Scientific's EV-to-EBIT

For the Biotechnology subindustry, Braxia Scientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Braxia Scientific's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braxia Scientific's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Braxia Scientific's EV-to-EBIT falls into.

Braxia Scientific EV-to-EBIT Calculation

Braxia Scientific's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	1.925	/	-9.727
	=	-0.20

Braxia Scientific's current Enterprise Value is C$1.93 Mil.
Braxia Scientific's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-9.73 Mil.

Braxia Scientific (XCNQ:BRAX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Braxia Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-9.727	/	3.14609
	=	-309.18 %

Braxia Scientific's Enterprise Value for the quarter that ended in Dec. 2023 was C$3.15 Mil.
Braxia Scientific's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-9.73 Mil.

Braxia Scientific EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Braxia Scientific (XCNQ:BRAX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

BRAXF:USA 4960:Germany

Address

700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6

Website

https://www.braxiascientific.com

Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines